Hepatitis C Virus
Perlegen and SC Liver Research Consortium to Collaborate on Interferon Response in Hepatitis C Patients
Published in Hepatitis Weekly, March 3rd, 2008
Perlegen Sciences, Inc., and the SC Liver Research Consortium (SCLRC), announced a collaboration to discover genetic variations that predict which patients with hepatitis C (HCV) are most likely to benefit from treatment. The parties will conduct large scale genetic studies on samples from hundreds of patients with HCV who have been treated, successfully and unsuccessfully, with interferon alfa and ribavirin, the current standard of care for this disease.
The cure rate for HCV patients treated with interferon alfa and ribavirin is roughly 50%. Unfortunately, irrespective of efficacy, the treatment results in serious side effects including flu-like symptoms, fatigue,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-03-03)
More Articles from Hepatitis Weekly
- Angiogenesis
Studies from V.R. Mas and co-researchers update current data on angiogenesis - Chromatography
Research results from J.I. Jorquera and co-authors update knowledge of chromatography - Enzyme Research
Data from M. Stahl et al provide new insights into enzyme research - Hepatitis
Research from University of Sherbrooke broadens understanding of hepatitis - Hepatitis B Virus
New findings reported from A.M. Dougherty and co-authors describe advances in hepatitis B virus - Hepatitis B Virus
New research on hepatitis B virus from Umea University summarized - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
